BVD 10

• Description :

  BVD 10, a neuropeptide Y (NPY) analogue peptide, is a highly selective NPY Y1 receptor antagonist. BVD10 significantly prevents NPY-induced glutamate increase. BVD 10 can be used for seizure research[1].

• CAS Number :

  [262418-00-8]

• UNSPSC :

  12352209

• Target :

  Neuropeptide Y Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Neurological Disease

• Smiles :

  OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(OC)=O)CC2=CC=C(C=C2)O)=O)=O)=O)=O)NC([C@H]([C@@H](C)CC)NC([C@H]3N(CCC3)C([C@H](CC(N)=O)NC([C@@H](N)[C@@H](C)CC)=O)=O)=O)=O

• Molecular Formula :

  C58H92N16O13

• Molecular Weight :

  1221.45

• References & Citations :

  [1]Meurs A, et al. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation. Neurosci Lett. 2012 Feb 29;510 (2) :143-7.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported